Onerji (60 mg + 7.5 mg)/mL solution for infusion

Licence holder

Mitsubishi Tanabe Pharma GmbH (all products →)

Active substances

Levodopa, Carbidopa

Dosage form

Solution for infusion

Route of administration

Subcutaneous use

ATC code

N04BA02

First authorised

27/04/2026

Prescription status

Product subject to prescription which may not be renewed (A)

Supply

Supply through pharmacies only

Legal basis

Full application (Article 8(3) of Directive No 2001/83/EC)

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.